• OPEN AN ACCOUNT
Indian Indices
Sensex
76,909.68 -325.78
( -0.42%)
Global Indices
Nasdaq
53,360.44 -120.34
(-0.23%)
Dow Jones
7,713.14 -52.92
(-0.68%)
Hang Seng
65,335.94 -2,124.79
(-3.15%)
Nikkei 225
10,747.45 19.41
(0.18%)
Forex
USD-INR
95.60 0.07
(0.07%)
EUR-INR
110.76 0.24
(0.21%)
GBP-INR
129.56 0.29
(0.22%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Transgene Biotek Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
526139
INE773D01018
-1.2142009
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
21.59
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Nyssa Corporation reports standalone net loss of Rs 12.82 crore in the March 2026 quarter
May 23,2026
Net Loss of Nyssa Corporation reported to Rs 12.82 crore in the quarter ended March 2026 as against net loss of Rs 2.88 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 as against Rs -0.26 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 12.02 crore in the year ended March 2026 as against net profit of Rs 0.36 crore during the previous year ended March 2025. Sales declined 87.04% to Rs 0.53 crore in the year ended March 2026 as against Rs 4.09 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0-0.26 100 0.534.09 -87
OPM %01396.15 --2316.98-3.18 -
PBDT-12.42-3.48 -257 -11.480.44 PL
PBT-12.42-3.48 -257 -11.480.44 PL
NP-12.82-2.88 -345 -12.020.36 PL